MORE►
biotech
The lobby of Verily's new Dallas HQ. [Photo: Verily]
Alphabet’s Health Tech Co. Verily Moves Headquarters from California to North Texas
by Nicole Ward, DRC Data Journalist | Jul 25, 2024
Verily, Alphabet's health tech subsidiary, is shifting its headquarters to Dallas-Fort Worth's Cypress Waters development, positioning the Google sister company at the heart of a growing healthcare and tech ecosystem.
by Quincy Preston |
Mar 5, 2024
According to a new report from Dallas-based JLL, society is accelerating the volume of data it creates at a rapid rate—and that data is foundational to how we work, live, and play. That's led to sharply increasing demand for data centers in a time of tightening supply, forcing a shift toward secondary and new, emerging markets.
MORE►
by Quincy Preston |
Oct 16, 2023
The NFL and NBA icons—Clark Hunt and Dirk Nowitzki—will kick off and wrap up discussions on innovation and investment. They add to an "impressive speaker lineup" including Nextdoor Co-Founder Nirav Tolia and other trailblazing speakers. Here's the full roster.
MORE►
by Lance Murray |
Oct 6, 2023
It's national pasta month. The Texas mother, author, and philanthropist—married to Matthew McConaughey—has partnered with the Dallas-connected "better-for-you" pasta brand launched by Arcadia Biosciences. To entice families, it offers a "clean-plate guarantee."
MORE►
Fatu in front and Najin in back are the last two known northern white rhinos alive on the planet. They live at Ol Pejeta conservancy in Kenya. [Photo: Ami Vitale]
Edge of Extinction: Pioneering Texas Biotech Colossal and BioRescue Race to Save the Northern White Rhino Species
by Quincy Preston and Lance Murray | Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
by Dallas Innovates | Staff Report |
Jul 28, 2023
“Delivering these projects will help to increase the speed-to-market and meet the overwhelming demand for new medicines," said Richard Meserole, president of Fluor’s advanced technologies and life sciences business.
MORE►
by Quincy Preston |
Jul 26, 2023
From an old car parts garage, Vertex Founder Joshua Boger launched the Boston-based biotech giant in 1989, running it for two decades as CEO. Boger "unretired" in June to join fast-moving Alkeus Pharmaceuticals as executive chairman.
In Dallas, he shared the "mistakes" that led to his success with innovators at Pegasus Park. Here's his no-holds-barred dose of truth for all entrepreneurs.
In Dallas, he shared the "mistakes" that led to his success with innovators at Pegasus Park. Here's his no-holds-barred dose of truth for all entrepreneurs.
MORE►
by Quincy Preston |
Jul 18, 2023
Parker Health's cloud Health Management System is the first in the U.S. to build on the Fast Healthcare Interoperability Resources—or FHIR—standard to create an interoperable, affordable, and compliant cloud-based platform. The Parker Suite aims to unify patient-centric data, biometrics, diagnostic tools, patient outcomes, care delivery, practitioner engagement, and pharmaceuticals for the healthcare ecosystem.
MORE►
[Image: sidmay/iStockphoto]
VanTrust Real Estate Announces New Science, Technology Division
by Lance Murray | Jun 6, 2023
VanTrust Real Estate, which has an office in Dallas, has announced a new division that is designed to match its real estate expertise and capital resources with both public and private sector clients in the life sciences, R&D, institutional, governmental, biotech, pharmaceutical and technology industries.
VanTrust Science + Technology is a real estate investment and development division that is focused on creating and deploying real estate strategies that drive value for its clients operating across these cutting-edge sectors....
MORE►
by Lance Murray |
Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
by Quincy Preston |
May 18, 2023
The multi-billion investment firm’s two-property industrial deal in Philadelphia builds on its commitment to grow in the “critical sector.” Closer to home, NexPoint recently unveiled plans for a massive life sciences district in Plano. The proposed 200-acre TxS development would be a "major economic catalyst" for North Texas, the firm’s founder said in February.
MORE►
by Lance Murray |
May 2, 2023
The "blood-brain barrier" acts like a highly selective firewall, preventing an estimated 98% of drugs from entering the brain—making it a major hurdle in the development of brain and central nervous system drugs. Lantern Pharma has recently developed what it calls "highly accurate AI algorithms" to predict the ability of a drug or compound to pass through the barrier.
MORE►
[Source Images: DRC, iStockphoto]
Dallas Regional Chamber Launches Life Science Recruitment Campaign
by Nicole Ward, DRC Data Journalist | Feb 22, 2023
The campaign builds on the region's thriving tech sector as the foundation of Dallas-Fort Worth's growing biotech and life science ecosystem. “What we’re seeing now is the cumulative effect of convergence across industries—and that gives DFW an edge," says Mike Rosa, the DRC's economic development chief.
The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
MORE►
by Sandra Engelland |
Feb 15, 2023
From AI to human longevity to xTech, North Texas experts George Brody of InfoNet of Things and Anurag Jain of Perot Jain, along with Mike Bechtel of Deloitte, predict a range of emerging technologies set to transform the world in 2023 and beyond.
MORE►
by Lance Murray |
Jan 11, 2023
Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....
MORE►
by Lance Murray |
Dec 8, 2022
Southlake-based Renibus Therapeutics—a clinical-stage biotech company developing innovative products for cardiorenal diseases—has received $33 million in bridge financing to help it advance three drugs in its pipeline. The drugs are currently in various phases of trials.
MORE►
